BioLife Solutions BLFS Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $99.77M+27.5% | $94.33M+26.4% | $90.65M— | $83.97M— | $78.27M— | ||
| —— | —— | —— | —— | $25.67M-1.9% | ||
| —— | —— | —— | —— | $52.37M+20.4% | ||
| $8.78M— | $7.57M— | —— | —— | —— | ||
| $9.78M+8.7% | $9.7M+8.6% | $9.27M— | $9.25M— | $9M— | ||
| $46.23M+11.2% | $45.37M+11.7% | $46.41M+35.4% | $43.66M+22.1% | $41.58M+4.0% | ||
| $87.69M— | $85.52M— | —— | —— | —— | ||
| -$16.71M— | -$17.23M— | —— | —— | —— | ||
| -16.7%— | -18.3%— | —— | —— | —— | ||
| $3.07M+5,279% | $2.71M+454% | $1.8M+304% | $1.07M+197% | $57K+105% | ||
| $4.96M+235% | $4.52M+204% | $2.43M+158% | $1.51M+135% | -$3.68M-172% | ||
| —— | —— | -$14.72M— | -$15.98M— | -$5.83M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$14.76M-776% | -$14.98M-21,497% | -$14.37M— | -$13.93M— | $2.18M— | ||
| -14.8%-17.6pp | -15.9%-16.0pp | -15.9%— | -16.6%— | 2.8%— | ||
| -$16.71M-628% | -$17.23M-239% | -$17.3M— | -$17.63M— | -$2.29M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioLife Solutions's revenue?
- BioLife Solutions (BLFS) generated $99.8M in revenue over the trailing twelve months, up 27.5% year over year.
- Is BioLife Solutions profitable?
- BioLife Solutions is not currently profitable: it reported a net loss of $14.5M over the trailing twelve months, a -68.7% net margin.
- What are BioLife Solutions's profit margins?
- Gross margin is 66.9% and operating margin is -16.7%, with a -68.7% net margin.
- What is BioLife Solutions's earnings per share?
- BioLife Solutions's diluted EPS over the trailing twelve months is $-0.30.
- Where does BioLife Solutions's income statement data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
